CTHIn ForceLegislation
National Health (Pharmaceutical Benefits) Regulations 2017
97Remuneration for chair and members of sub‑committees
Start here
Get a plain-English read of 97
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits) Regulations 2017.
#### 97 Remuneration for chair and members of sub‑committees
Fees and allowances payable to chairs
(1) For the purposes of paragraph 140(a) of the Act, the fees and allowances payable to the Chair of the Drug Utilisation Sub‑Committee and the Chair of the Economics Sub‑Committee are the amounts payable to the Chairperson of the Pharmaceutical Services Federal Committee of Inquiry in accordance with a determination made by the Remuneration Tribunal.
Fees and allowances payable to other members
(2) For the purposes of paragraph 140(a) of the Act, the fees and allowances payable to a member (other than the Chair) of the Drug Utilisation Sub‑Committee or the Economics Sub‑Committee are the amounts payable to a member (other than the Chairperson) of the Pharmaceutical Services Federal Committee of Inquiry in accordance with a determination made by the Remuneration Tribunal.
Definitions
(3) In this section:
> Drug Utilisation Sub‑Committee means the sub‑committee of that name established under section 101A of the Act.
> Economics Sub‑Committee means the sub‑committee of that name established under section 101A of the Act.